查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402577

第三代定序儀市場：依技術類型、按組件、按應用、按最終用戶、按地區

Third Generation Sequencing Market, By Type of Technology, By Component, By Application:, By End-User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球第三代定序市值為6.080億美元，預計2030年將達22.973億美元，2023年至2030年複合年成長率為21.1%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 6.008 億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 21.10% 2030年市場規模預測 22.973 億美元
圖 1. 2023 年第三代定序儀的全球市場佔有率(%)（按地區）
第三代定序市場-IMG1

第三代定序（也稱為長讀長定序）是一類DNA定序方法。第三代定序儀透過在單分子層級上讀取序列來工作，並且可以產生比目前方法長得多的讀取。它能夠產生比第二代定序儀（也稱為次世代定序儀）更長的讀取。此外，第三代定序正成為 cDNA定序的「黃金標準」技術。

市場動態：

慢性病和感染疾病的傳播、臨床診斷應用的增加、基因組學應用的擴大、對藥物研發和市場開拓的更多關注、與傳統技術相比效率的提高等因素正在推動對第三代測序儀的需求。這些是預計推動市場成長的主要因素。

例如，隨著慢性病負擔的日益加重，基於第三代定序技術的設備的使用和需求也在迅速成長。 TGS技術可用於研究慢性病的基因表現，有助於了解慢性病的分子機制。根據世界衛生組織（WHO）2023年9月的報告，非傳染性疾病（NCD）每年導致4,100萬人死亡，佔全球死亡人數的74%。大多數非傳染性疾病死亡是由心血管疾病引起的，每年死亡人數為 1,790 萬人，其次是癌症（930 萬人）、慢性呼吸道疾病（410 萬人）和糖尿病（200 萬人）。

此外，根據美國疾病管制與預防中心 (CDC) 的數據，心臟病、癌症和糖尿病等慢性疾病是美國死亡和殘疾的主要原因。

本研究的主要特點

  • 本報告對全球第三代定序儀市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
  • 它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 它根據以下參數（例如公司亮點、產品系列、主要亮點、財務實績和策略）介紹了全球第三代定序市場的主要企業。
  • 該報告的見解將使行銷人員和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略負責人資訊的決策。
  • 全球第三代定序儀市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球第三代定序市場的各種策略矩陣來促進他們的決策。

目錄：

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 精準醫療需求不斷成長
    • 高成本和技術挑戰
    • TGS 平台的採用率提高
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第 4 章 第三代定序市場 -冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第 5 章 第三代定序儀市場，依技術分類，2023-2030 年

  • 單分子即時 (SMRT) 定序
  • 奈米孔定序
  • 合成長讀定序

第 6 章 第三代定序儀市場，依組成部分，2020-2030 年

  • 產品
  • 工具
  • 試劑及消耗品
  • 服務

第 7 章 2023-2030 年第三代定序儀市場（依應用）

  • 基因組序列測定
  • 磊晶
  • 轉錄組學
  • 宏基因體學
  • 其他

第 8 章 第三代定序儀市場，依最終使用者分類，2023-2030 年

  • 生物製藥公司
  • 醫院和診所
  • 合約研究組織（CRO）
  • 其他

第 9 章 2018-2030 年第三代定序儀市場（按地區）

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章競爭形勢

  • PacBio
  • Oxford Nanopore Technologies, Ltd.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Agilent Technologies, Inc.
  • GenapSys Inc.
  • Loop Genomics
  • Nabsys, Inc.
  • Genia Technologies, Inc.
  • Stratos Genomics, Inc.
  • GATC Biotech AG
  • Phase Genomics, Inc.

第11章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5721

The global Third Generation Sequencing market was valued at US$ 600.8 Mn in 2023 and is forecast to reach a value of US$ 2,297.3 Mn by 2030 at a CAGR of 21.1% between 2023 and 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 600.8 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 21.10% 2030 Value Projection: US$ 2,297.3 Mn
Figure 1. Global Third Generation Sequencing Market Share (%), by Region, 2023
Third Generation Sequencing Market - IMG1

Third-generation sequencing (also known as long-read sequencing) is a class of DNA sequencing methods. Third-generation sequencing works by reading nucleotide sequences at a single molecule level, which is capable of producing substantially much longer reads than the current methods. It has the ability to generate longer reads than second-generation sequencing, also known as next-generation sequencing. Moreover, third-generation sequencing has emerged as the 'gold-standard' technology for cDNA sequencing.

Market Dynamics:

Rising prevalence of chronic and infectious diseases, increasing applications in clinical diagnosis, growing applications of genomics, rise in focus on drug discovery and development, and growing efficiency compared to traditional technologies are major factors expected to propel growth of the global third generation sequencing market.

For instance, with the rise in burden of chronic disease, the usage or demand for third-generation sequencing technology-based devices is also increasing with a rapid pace. TGS technologies can be utilized in studying gene expression of chronic diseases as it help in understanding their molecular mechanisms. According to the World Health Organization (WHO), September 2023 report, non-communicable diseases (NCDs) kill 41 million individuals each year, equivalent to 74% of all deaths worldwide. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Moreover, according to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global third generation sequencing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global third generation sequencing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include PacBio , Oxford Nanopore Technologies, Ltd., BGI Genomics Co., Ltd., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., GenapSys Inc., Loop Genomics, Nabsys, Inc., Genia Technologies, Inc., Stratos Genomics, Inc., GATC Biotech AG, and Phase Genomics, Inc., among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global third generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global third generation sequencing market.

Detailed Segmentation:

  • By Technology:
    • Single-Molecule Real-Time (SMRT) Sequencing
    • Nanopore Sequencing
    • Synthetic long-read sequencing
  • By Component:
    • Products
    • Instruments
    • Reagents and consumables
    • Services
  • By Application:
    • Genome Sequencing
    • Epigenetics
    • Transcriptomics
    • Metagenomics
    • Others
  • By End-user:
    • Biopharmaceutical companies
    • Hospitals and clinics
    • Contract research organizations (CROs)
    • Others (Academic and research institutes)
  • By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • PacBio
    • Oxford Nanopore Technologies, Ltd.
    • BGI Genomics Co., Ltd.
    • F.Hoffmann-La Roche AG
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN N.V.
    • Agilent Technologies, Inc.
    • GenapSys Inc.
    • Loop Genomics
    • Nabsys, Inc.
    • Genia Technologies, Inc.
    • Stratos Genomics, Inc.
    • GATC Biotech AG
    • Phase Genomics, Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Third Generation Sequencing, By Technology
    • Market Third Generation Sequencing, By Component
    • Market Third Generation Sequencing, By Application
    • Market Third Generation Sequencing, By End User
    • Market Third Generation Sequencing, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing Demand for Precision Medicine
    • High Cost & Technical Challenges
    • Increasing Adoption of TGS Platforms
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Third Generation Sequencing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Third Generation Sequencing Market, By Technology, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2023 - 2030
    • Segment Trends
  • Single-molecule real-time (SMRT) sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Nanopore Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Synthetic long-read sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Third Generation Sequencing Market, By Component, 2020-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2023 - 2030
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Instruments
  • Reagents and consumables
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Third Generation Sequencing Market, By Application, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Genome Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Epigenetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Transcriptomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Metagenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Third Generation Sequencing Market, By End User, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Contract research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Third Generation Sequencing Market, By Geography, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • PacBio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oxford Nanopore Technologies, Ltd.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • GenapSys Inc.
  • Loop Genomics
  • Nabsys, Inc.
  • Genia Technologies, Inc.
  • Stratos Genomics, Inc.
  • GATC Biotech AG
  • Phase Genomics, Inc.
  • Analyst Views

11. Section

  • Research Methodology
  • About us